Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1300 (104th)

FDA Export Reform and Enhancement Act of 1995

referredUnited States· United States Congress· EN

Introduced

22 March 1995

Last action

10 April 1995 · Referred

Status

Referred to the Subcommittee on Health and Environment.

Sponsors

Rep. Upton, Fred [R-MI-6], Rep. Greenwood, James C. [R-PA-8], Sen. Burr, Richard [R-NC], Rep. Norwood, Charles W. [R-GA-9], Sen. Coburn, Tom [R-OK], Rep. Bilbray, Brian P. [R-CA-50], Rep. Hastert, J. Dennis [R-IL-14], Rep. Ganske, Greg [R-IA-4], Rep. Towns, Edolphus [D-NY-10], Rep. Cox, Christopher [R-CA-48], Rep. Gillmor, Paul E. [R-OH-5], Rep. Moorhead, Carlos J. [R-CA-22], Rep. Hall, Ralph M. [R-TX-4], Rep. Bryant, Ed [R-TN-7], Rep. Knollenberg, Joe [R-MI-9], Rep. Chrysler, Dick [R-MI-8], Rep. Camp, Dave [R-MI-4], Rep. Barcia, James A. [D-MI-5], Rep. Ehlers, Vernon J. [R-MI-3], Rep. Martini, William J. [R-NJ-8], Rep. Calvert, Ken [R-CA-41], Rep. Rohrabacher, Dana [R-CA-48], Rep. McIntosh, David M. [R-IN-2], Sen. Chambliss, Saxby [R-GA], Rep. Cooley, Wes [R-OR-2], Rep. Brewster, Bill K. [D-OK-3], Rep. Frelinghuysen, Rodney P. [R-NJ-11], Rep. Chabot, Steve [R-OH-1], Rep. Traficant, James A., Jr. [D-OH-17], Rep. Solomon, Gerald B. H. [R-NY-22], Rep. Oxley, Michael G. [R-OH-4], Rep. Chenoweth-Hage, Helen [R-ID-1], Rep. Ramstad, Jim [R-MN-3], Rep. Frisa, Dan [R-NY-4], Rep. Molinari, Susan [R-NY-13], Rep. Whitfield, Ed [R-KY-1], Rep. Jones, Walter B., Jr. [R-NC-3], Rep. Coble, Howard [R-NC-6], Rep. Clayton, Eva M. [D-NC-1], Rep. Stenholm, Charles W. [D-TX-17], Rep. Heineman, Frederick K. (Fred) [R-NC-4], Rep. Goodlatte, Bob [R-VA-6], Rep. Klug, Scott L. [R-WI-2], Rep. Funderburk, David [R-NC-2], Rep. English, Phil [R-PA-3], Rep. Ballenger, Cass [R-NC-10], Rep. Fox, Jon D. [R-PA-13], Rep. Myrick, Sue Wilkins [R-NC-9]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Official sourceDownload fileView documentsShare

Summary

FDA Export Reform and Enhancement Act of 1995 - Amends the Federal Food, Drug, and Cosmetic Act (FDCA) to modify the circumstances in which a drug, device, or biological product (including a partially processed biological product) may be exported.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 22 March 1995

    Introduced

    Introduced in House

    Source: IntroReferral

  2. 22 March 1995

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 22 March 1995

    Introduced

    Referred to the House Committee on Commerce.

    Source: IntroReferral

  4. 10 April 1995

    Referred

    Referred to the Subcommittee on Health and Environment.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 22 March 1995

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 22 March 1995

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 22 March 1995

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 61 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.